N1-(4-(4-methoxyphenyl)pyrimidin-2-yl)benzene-1,3-diamine

ID: ALA4098016

PubChem CID: 137661113

Max Phase: Preclinical

Molecular Formula: C17H16N4O

Molecular Weight: 292.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2ccnc(Nc3cccc(N)c3)n2)cc1

Standard InChI:  InChI=1S/C17H16N4O/c1-22-15-7-5-12(6-8-15)16-9-10-19-17(21-16)20-14-4-2-3-13(18)11-14/h2-11H,18H2,1H3,(H,19,20,21)

Standard InChI Key:  LTHCKHIXPOIYDD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   10.2052  -10.5492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2041  -11.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9121  -11.7777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6218  -11.3682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6190  -10.5456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9103  -10.1403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9051   -9.3259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6132   -8.9158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6111   -8.0994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9016   -7.6921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1928   -8.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1984   -8.9223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8981   -6.8749    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1886   -6.4694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3301  -11.7757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0372  -11.3660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7422  -11.7739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4488  -11.3649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4480  -10.5468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7346  -10.1395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0310  -10.5509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7305   -9.3223    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  6  7  1  0
 10 13  1  0
 13 14  1  0
  4 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 20 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4098016

    ---

Associated Targets(Human)

CDK5 Tchem Cyclin-dependent kinase 5 (3021 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 292.34Molecular Weight (Monoisotopic): 292.1324AlogP: 3.48#Rotatable Bonds: 4
Polar Surface Area: 73.06Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.48CX Basic pKa: 4.48CX LogP: 3.21CX LogD: 3.21
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.72Np Likeness Score: -1.19

References

1. Toviwek B, Suphakun P, Choowongkomon K, Hannongbua S, Gleeson MP..  (2017)  Synthesis and evaluation of the NSCLC anti-cancer activity and physical properties of 4-aryl-N-phenylpyrimidin-2-amines.,  27  (20): [PMID:28927795] [10.1016/j.bmcl.2017.08.063]

Source